Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002219075 | SCV002379428 | likely benign | 5-Oxoprolinase deficiency | 2024-07-09 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004045664 | SCV003694287 | uncertain significance | not specified | 2022-05-25 | criteria provided, single submitter | clinical testing | The c.1933C>T (p.R645C) alteration is located in exon 14 (coding exon 13) of the OPLAH gene. This alteration results from a C to T substitution at nucleotide position 1933, causing the arginine (R) at amino acid position 645 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Breakthrough Genomics, |
RCV004706304 | SCV005222363 | likely benign | not provided | criteria provided, single submitter | not provided |